Browse
The new Drug Price Negotiation Program applied to 10 drugs this first year, including two SGLT2 inhibitors.
Rachel Nell Meyer
Stephanie L. Donahue
,
Daniil Shimonov
,
Andrew Bohmart
, and
Sri Lekha Tummalapalli
Cindy X. Cai
,
Ian C. Han
, and
Jia Hwei Ng